Activated partial thromboplastin time overestimates anti-coagulation in left ventricular assist device patients

J Heart Lung Transplant. 2014 Dec;33(12):1312-4. doi: 10.1016/j.healun.2014.08.022. Epub 2014 Sep 16.

Authors

Colleen K McIlvennan¹, Robert L Page 2nd², Amrut V Ambardekar¹, Andreas Brieke¹, JoAnn Lindenfeld¹

Affiliations

¹ Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado.
² School of Pharmacy, University of Colorado, Aurora, Colorado.

PMID: 25443872
DOI: 10.1016/j.healun.2014.08.022

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Antibodies / blood
Anticoagulants / pharmacology
Anticoagulants / therapeutic use*
Blood Coagulation / drug effects
Blood Coagulation / physiology*
Factor X / immunology
Female
Heart Failure / blood*
Heart Failure / therapy*
Heart-Assist Devices / adverse effects*
Heparin / pharmacology
Heparin / therapeutic use
Humans
Incidence
Male
Middle Aged
Partial Thromboplastin Time*
Prospective Studies
Risk Factors
Thrombosis / epidemiology
Thrombosis / prevention & control*
Ventricular Dysfunction, Left / blood
Ventricular Dysfunction, Left / therapy
Warfarin / pharmacology
Warfarin / therapeutic use

Substances

Antibodies
Anticoagulants
Warfarin
Factor X
Heparin